SC
BIO icon

SummitTX Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

SummitTX Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$593K Buy
+2,018
New +$572K 0.02% 560
2025
Q3 		– Sell
-1,553
Closed -$375K – 764
2025
Q2 		$375K Sell
1,553
-1,616
-51% -$382K 0.02% 564
2025
Q1 		$772K Buy
+3,169
New +$953K 0.03% 452

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

SummitTX Capital's BIO Position: Q2 2026 in Review

SummitTX Capital opened a new position in Bio-Rad Laboratories Class A (BIO) in Q2 2026: 2,018 shares worth $593K. The stake represents 0.02% of the portfolio and ranks #560 among its holdings. This is a return to the name: SummitTX Capital previously reported a position in BIO as recently as Q2 2025.

SummitTX Capital first reported a position in BIO in Q1 2025 and has held it in 3 quarters since. The position peaked at $772K in Q1 2025. 399 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • SummitTX Capital held 2,018 shares of Bio-Rad Laboratories Class A worth $593K as of Q2 2026.
  • Bio-Rad Laboratories Class A was a new SummitTX Capital position in Q2 2026.
  • Bio-Rad Laboratories Class A made up 0.02% of SummitTX Capital's portfolio in Q2 2026, its #560 holding.
  • SummitTX Capital first reported a position in Bio-Rad Laboratories Class A in Q1 2025 and has held it in 3 quarters since.
  • SummitTX Capital's Bio-Rad Laboratories Class A position peaked at $772K in Q1 2025.
  • 399 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on SummitTX Capital's 13F filing for Q2 2026, filed 14 Aug 2026.